Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care – The countrywide cross‐sectional AUSTRO‐PROFIT study

Aims This study assessed the achievement rates of metabolic risk factor targets and their association with clinical characteristics and comorbidities among individuals with type 2 diabetes (T2D) treated in the primary care in Austria. Materials and Methods A countrywide cross‐sectional study, the AU...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes, obesity & metabolism obesity & metabolism, 2025-01, Vol.27 (1), p.111-122
Hauptverfasser:	Sourij, Harald, Azhar, Kehkishan, Aziz, Faisal, Kojzar, Harald, Sourij, Caren, Fasching, Peter, Clodi, Martin, Ludvik, Bernhard, Mader, Julia K., Resl, Michael, Rega‐Kaun, Gersina, Ress, Claudia, Stechemesser, Lars, Stingl, Harald, Tripolt, Norbert J., Wascher, Thomas, Kaser, Susanne
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Austria - epidemiology Blood Pressure Cardiometabolic Risk Factors Cardiovascular diseases Cardiovascular Diseases - epidemiology Cholesterol Cholesterol, LDL - blood clinical characteristics comorbidities Comorbidity Cross-Sectional Studies Diabetes Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - epidemiology Female Glycated Hemoglobin - analysis Glycated Hemoglobin - metabolism Hemoglobin Humans Low density lipoprotein Male metabolic risk factor targets Metabolism Microvasculature Middle Aged Original Primary care Primary Health Care - statistics & numerical data Risk Factors type 2 diabetes type 2 diabetes care
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Aims This study assessed the achievement rates of metabolic risk factor targets and their association with clinical characteristics and comorbidities among individuals with type 2 diabetes (T2D) treated in the primary care in Austria. Materials and Methods A countrywide cross‐sectional study, the AUSTRO‐PROFIT, was conducted in Austria from 2021 to 2023 on 635 individuals with T2D. Metabolic risk factor targets were defined as the percentage of people achieving low‐density lipoprotein cholesterol (LDL‐C)
ISSN:	1462-8902 1463-1326 1463-1326
DOI:	10.1111/dom.15988